Produkte von TargetMol

TargetMol aus Boston (Massachusetts) wurde 2015 gegründet und ist ein Experte für Wirkstoffscreening in der Life Science-Community. Das Unternehmen bietet diverse Substanzbibliotheken, darunter FDA-zugelassene Bibliotheken, an und deckt ein breites Spektrum an niedermolekularen Verbindungen wie Inhibitoren und Agonisten sowie rekombinante Proteine und Naturstoffe ab. Die Produkte von TargetMol werden von Forschenden weltweit in Bereichen wie Krebsforschung, Neurobiologie, Inflammation, Immunologie oder Metabolismus eingesetzt.

Mehr Informationen unter: www.targetmol.com

Zu den Katalogen von TargetMol

Für die Filterung wurden keine Ergebnisse gefunden!

Steroid sulfatase/17beta-HSD1-IN-1

Artikelnummer: TGM-T61716-100mg

Description: Steroid sulfatase/17beta-HSD1-IN-1 is a highly effective inhibitor of steroid sulfatase and 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) activities, with an IC50 value of 28 nM against cellular human steroid sulfatase. This compound holds significant potential for investigating...

MW:

386.42 D

ab 1.440,00 €

Detailansicht

Bewerten

mPGES-1-IN-1

Artikelnummer: TGM-T61718-100mg

Description: MPGES-1, a promising therapeutic target for the next generation of anti-inflammatory drugs in treating inflammatory diseases, possesses an IC50 value of 0.03 µM for mPGES-1-IN-1. Target: Others

MW:

386.43 D

ab 1.440,00 €

Detailansicht

Bewerten

Pol I-IN-1

Artikelnummer: TGM-T61720-100mg

Description: Pol I-IN-1 is a potent inhibitor of RNA polymerase I (Pol I), specifically targeting the large catalytic subunit RPA194, with an inhibition concentration (IC50) of 0.21 µM [1]. Target: Others

MW:

386.45 D

ab 1.440,00 €

Detailansicht

Bewerten

SS-RJW100

Artikelnummer: TGM-T61723-100mg

Description: SS-RJW100 is an enantiomer of RJW100, known as a racemic agonist that targets two nuclear receptors: liver receptor homolog 1 (LRH-1) and steroidogenic factor 1 (SF-1). In vitro experiments reveal that SS-RJW100 promotes the recruitment of coregulator protein fragments and enhances the interaction with...

MW:

386.57 D

ab 1.440,00 €

Detailansicht

Bewerten

SB 258741 hydrochloride

Artikelnummer: TGM-T61724-100mg

Description: SB 258741 hydrochloride is a potent antagonist of the 5-HT 7 receptor, designed specifically for studying schizophrenia [1]. Target: Others

MW:

386.98 D

ab 1.440,00 €

Detailansicht

Bewerten

VU0463271 quarterhydrate

Artikelnummer: TGM-T61725-100mg

Description: VU0463271 quarterhydrate is a potent KCC2 antagonist with an IC50 of 61 nM [1]. Target: Others

MW:

387 D

ab 1.450,00 €

Detailansicht

Bewerten

EGFR/HER2-IN-6

Artikelnummer: TGM-T61732-100mg

Description: EGFR/HER2-IN-6 (compound 43) is a dual EGFR/HER2 and DHFR inhibitor with potent activity against EGFR kinase, HER2 kinase, and DHFR, characterized by IC50 values of 0.122 µM, 0.078 µM, and 0.585 µM, respectively. This compound displays notable anticancer properties in various cancer cell lines, while...

MW:

387.46 D

ab 1.440,00 €

Detailansicht

Bewerten

Quorum Sensing-IN-1

Artikelnummer: TGM-T60595-100mg

Description: Quorum Sensing-IN-1 [QSI-1] is a small-molecule inhibitor targeting quorum sensing. Target: Others

MW:

290.36 D

ab 1.440,00 €

Detailansicht

Bewerten

hCAIX/XII-IN-5

Artikelnummer: TGM-T60602-100mg

Description: hCAIX/XII-IN-5 (Coumarin 9a) is an inhibitor of carbonic anhydrase (CA) with excellent selectivity for hCA IX/XII, displaying Kis of 93.3 nM and 85.7 nM over hCA I and hCA II, respectively. It exhibits anti-proliferative activities in cancer cells, delaying the cell cycle and inducing apoptosis [1]....

MW:

291.3 D

ab 1.440,00 €

Detailansicht

Bewerten

Antibacterial agent 80

Artikelnummer: TGM-T60634-100mg

Description: Antibacterial agent 80 (compound 20) demonstrates antibacterial activity [1]. Target: Others

MW:

295.47 D

ab 1.440,00 €

Detailansicht

Bewerten

Glutamate-5-kinase-IN-2

Artikelnummer: TGM-T60645-100mg

Description: Glutamate-5-kinase-IN-2 (compound 54) is a potent glutamate-5-kinase (G5K) inhibitor with an MIC of 4.2 µM, exhibiting G5K inhibition by promoting conformational changes at the L-glutamate binding site. Glutamate-5-kinase-IN-2 has potential for anti-TB research [1]. Target: Others

MW:

296.73 D

ab 1.440,00 €

Detailansicht

Bewerten